# DelveInsight Business Research LLP

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/delveinsight-business-research-llp
Canonical HTML page: https://gethealthbrief.com/entity/delveinsight-business-research-llp

## Timeline

- **2034**: Market Milestone — Global nanomedicine market projected to surpass the $550 billion mark.
- **2028**: Regulatory Maturity — Anticipated standardization of regulatory pathways for nanosimilars and complex nano-formulations.
- **2024**: Pipeline Expansion — Increased R&D focus on non-vaccine applications, particularly in targeted oncology and neurology.
- **2020**: LNP Validation — Global rollout of mRNA vaccines validates lipid nanoparticle delivery at a massive scale.

## Recent coverage (2 stories)

### Global Minimally Invasive Surgical Market Set for 7% CAGR Through 2034
2026-03-11 23:18:20 · Sentiment: Positive · Impact: 6/10 · Sources: 2

A new DelveInsight report projects a steady 7% CAGR for the minimally invasive surgical devices (MISD) market through 2034, driven by technological leaps in robotics and a global shift toward outpatient care. This expansion reflects a broader healthcare transition prioritizing reduced recovery times and improved clinical outcomes over traditional open surgeries.
Full story: https://gethealthbrief.com/story/minimally-invasive-surgical-market-growth-2034

### Nanomedicine Market Forecast to Surpass $550 Billion by 2034
2026-03-05 00:51:49 · Sentiment: Positive · Impact: 7/10 · Sources: 2

The global nanomedicine market is projected to exceed $550 billion by 2034, driven by rapid advancements in targeted drug delivery and precision therapeutics. This growth reflects a fundamental shift in how chronic diseases, particularly oncology and cardiovascular conditions, are treated at the molecular level.
Full story: https://gethealthbrief.com/story/global-nanomedicine-market-growth-2034-forecast

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.